A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...

From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...

Vir Biotechnology has dosed the first patient in one of three expansion cohorts in its ongoing Phase I clinical trial of ...

Dr. Sandy Srinivas explains how age, comorbidities and medications influence personalized prostate cancer treatment decisions ...

The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...

PRO-XTEN dual masking aims to keep the engager inactive in circulation, activate within tumor protease-rich microenvironments ...

A prostate cancer patient from Worthing has become the first in Sussex to receive an innovative new treatment. Darius Aibara, ...

Survivorship in metastatic prostate cancer is seen as chronic management, focusing on quality of life through physical and emotional management. Carotuximab combined with Erleada shows a favorable ...

Myriad Genetics Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that ...

Researchers have identified a surprising metabolic effect of a widely used diabetes drug in men undergoing prostate cancer treatment.

Brian Holmes is the first man in the UK and only the fifth in the world to take part in the clinical trial A prostate cancer patient hopes a new treatment can help prolong the lives of thousands of ...